- Phyathai Hospital Thailand Establishment Date – Group Development History & Assisted Reproduction Center Overview
-
Phyathai Hospitals Group, established in 1976, is a leading private healthcare provider in Thailand. Phyathai 2 Hospital (founded 1987) and Phyathai 3 Hospital (founded 1997) both house assisted reproduction centers offering IVF, ICSI, PGT, and more. This article outlines Phyathai Hospital's development timeline and the establishment history of its fertility centers, helping users understand the institution's background and current status in assisted reproduction.
- How Good is Thailand's 3D Hysteroscopy Technology? Clinical Application Assessment in Reproductive Medicine
-
Thailand's 3D hysteroscopy technology is a three-dimensional imaging examination method in the field of reproductive medicine, used to assess uterine cavity morphology and endometrial condition. This article analyzes its applicable scenarios, examination process, technical advantages, and limitations from a clinical application perspective, helping patients rationally understand the actual role and positioning of this examination in the IVF cycle.
- Are Thai Surrogacy Agencies Reliable? How to Judge Legitimacy and Legal Risks
-
The reliability of Thai surrogacy agencies depends on legal compliance, agency qualifications, fee transparency, etc. Thailand prohibits commercial surrogacy, allowing only surrogacy between relatives. This article analyzes how to judge whether an agency is legitimate from legal, medical, and procedural perspectives, helping users identify risks and make rational decisions.
- Thailand Assisted Reproductive Technology World Ranking & International Competitiveness Real Data Deep Analysis
-
Thailand's assisted reproductive technology is a global leader, ranking in the top three in Asia. Based on international authoritative data from ESHRE, ICMART, etc., this article analyzes Thailand's international competitiveness in ovulation induction protocols, embryo culture, PGT technology, etc., helping users objectively understand the true level, advantages, and limitations of Thailand's assisted reproductive technology.
- Current Status of Oocyte Cryopreservation Technology in Thailand and Analysis of Suitable Candidates
-
Oocyte cryopreservation in Thailand primarily uses vitrification, with post-thaw survival rates exceeding 90%. Suitable for women needing to delay childbearing due to age, disease, or career planning. Technology effectiveness is strongly age-related; clinical pregnancy rates from eggs frozen before age 35 are significantly higher than after age 40. Comprehensive assessment of ovarian reserve is required.